Cite
HARVARD Citation
Rea, D. et al. (2018). Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group. Cancer. 124 (14), pp. 2956-2963. [Online].